Primeri uporabe Concurrent administration v Angleški in njihovi prevodi v Slovenski
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Official/political
-
Programming
Concurrent administration with ipilimumab.
Based on these preliminary data, the concurrent administration of ipilimumab and vemurafenib is not recommended.
Concurrent administration of TNF-alpha inhibitor and anakinra.
Based on these preliminary data, the concurrent administration of ipilimumab and vemurafenib is not recommended.
Na osnovi teh preliminarnih podatkov sočasna uporaba ipilimumaba in vemurafeniba ni priporočljiva.Concurrent administration with Teysuno should be avoided.
The combination of Humira andanakinra is not recommended(see section 4.4“ Concurrent administration of TNF-antagonists and anakinra”).
Kombinacija Humire inanakinre ni priporočljiva(glejte poglavje 4. 4“ Sočasna uporaba antagonistov TNF in anakinre”).Concurrent administration of TNF-alpha inhibitor and anakinra.
Sočasno zdravljenje z zaviralcem TNF-alfa in anakinro.The combination of Humira andabatacept is not recommended(see section 4.4“ Concurrent administration of TNF-antagonists and abatacept”).
Kombinacija Humire inabatacepta ni priporočljiva(glejte poglavje 4. 4“ Sočasna uporaba antagonistov TNF in abatacepta”).Concurrent administration of salmeterol and idelalisib is not recommended.
Sočasno dajanje salmeterola in idelaliziba se ne priporoča.NSAIDs Animal trials have shown that the concurrent administration of very high doses of fluoroquinolones and certain NSAIDs(but not acetylsalicylic acid) may provoke convulsions.
NSAID Poskusi na živalih so pokazali, da lahko sočasna uporaba zelo velikih odmerkov fluorokinolonov in nekaterih nesteroidnih protivnetnih zdravil(vendar ne acetilsalicilne kisline) povzroči konvulzije.Concurrent administration of salmeterol and Genvoya is not recommended.
Sočasno dajanje salmeterola in zdravila Genvoya se ne priporoča.Concurrent administration of potential nephrotoxic drugs should be avoided.
Concurrent administration of potential nephrotoxic drugs should be avoided.
Hkratnemu dajanju s potencialno nefrotoksičnimi zdravili se je potrebno izogniti.Concurrent administration of potential nephrotoxic drugs should be avoided.
Concurrent administration of potential nephrotoxic drugs should be avoided.
Sočasnemu dajanju zdravil, ki lahko imajo nefrotoksične učinke, se je treba izogibati.Concurrent administration of agents likely to cause significant hypotension is not recommended.
Sočasnega dajanja zdravil, ki lahko povzročijo večjo hipotenzijo, ne priporočamo.Concurrent administration of Aptivus, co-administered with low dose ritonavir, is not recommended.
Sočasnega dajanja zdravila Aptivus ob hkratnih majhnih odmerkih ritonavirja ne priporočajo.The concurrent administration of Kineret and etanercept or other TNF antagonists is not recommended(see section 4.5).
Sočasna uporaba zdravila Kineret in etanercepta ali drugih antagonistov TNF ni priporočljiva(glejte poglavje 4.5).Concurrent administration of probenicid may affect renal excretion of the conjugation product of sodium phenylbutyrate.
Sočasno dajanje probenecida lahko vpliva na izločanje konjugiranega produkta natrijevega fenilbutirata preko ledvic.Concurrent administration of medicinal products with cardiotoxicity or blood pressure lowering effects may increase the toxicity of Ceplene.
Sočasno zdravljenje s kardiotoksičnimi zdravili ali zdravili, ki znižujejo krvni tlak, lahko poveča toksičnost zdravila Ceplene.Concurrent administration of cabozantinib with the strong CYP3A4 inducer rifampicin resulted in a decrease in cabozantinib plasma exposure.
Sočasna uporaba kabozantiniba z močnim induktorjem CYP3A4, rifampicinom, je povzročila zmanjšanje izpostavljenosti kabozantiniba v plazmi.Concurrent administration of cabozantinib with the strong CYP3A4 inhibitor ketoconazole resulted in an increase in cabozantinib plasma exposure.
Sočasna uporaba kabozantiniba z močnim zaviralcem CYP3A4, ketokonazolom, je povzročila povečanje izpostavljenosti kabozantiniba v plazmi.Concurrent administration of etanercept and anakinra has been associated with an increased risk of serious infections and neutropenia compared to etanercept alone.
Sočasna uporaba etanercepta in anakinre je bila povezana s povečanim tveganjem za pojav resnih okužb in nevtropenije v primerjavi z zdravljenjem samo z etanerceptom.Concurrent administration of LIFMIOR and anakinra has been associated with an increased risk of serious infections and neutropenia compared to LIFMIOR alone.
Sočasna uporaba zdravila LIFMIOR in anakinre je bila povezana s povečanim tveganjem za pojav resnih okužb in nevtropenije v primerjavi z zdravljenjem samo z zdravilom LIFMIOR.Concurrent administration of substances which alter immune function(e.g. corticosteroids or non steroidal anti-inflammatory drugs) may reduce the efficacy of the product.
Sočasna uporaba snovi, ki spreminjajo delovanje imunskega sistema(npr. kortikosteroidi ali nesteroidna protivnetna zdravila), lahko zmanjša uspešnost zdravljenja.Concurrent administration of ketoconazole, a known potent inhibitor of CYP3A4, does not inhibit the elimination of paclitaxel in patients; thus, both medicinal products may be administered together without dosage adjustment.
Sočasno dajanje ketokonazola, znanega zaviralca CYP3A4, pri bolnikih ne zavre eliminacije paklitaksela, zato lahko obe zdravili dajemo Concurrent administration of TNF-antagonists and abatacept has been associated with an increased risk of infections including serious infections compared to TNF-antagonists alone, without increased clinical benefit.
Sočasna uporaba antagonistov TNF in abatacepta je povezana s povečanim tveganjem za okužbe, vključno z resnimi okužbami, brez večje klinične prednosti, v primerjavi z 
